285 related articles for article (PubMed ID: 35337019)
1. A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.
May DG; Martin-Sancho L; Anschau V; Liu S; Chrisopulos RJ; Scott KL; Halfmann CT; Díaz Peña R; Pratt D; Campos AR; Roux KJ
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337019
[TBL] [Abstract][Full Text] [Related]
2. A BioID-derived proximity interactome for SARS-CoV-2 proteins.
May DG; Martin-Sancho L; Anschau V; Liu S; Chrisopulos RJ; Scott KL; Halfmann CT; Peña RD; Pratt D; Campos AR; Roux KJ
bioRxiv; 2021 Sep; ():. PubMed ID: 34580671
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
Liu X; Huuskonen S; Laitinen T; Redchuk T; Bogacheva M; Salokas K; Pöhner I; Öhman T; Tonduru AK; Hassinen A; Gawriyski L; Keskitalo S; Vartiainen MK; Pietiäinen V; Poso A; Varjosalo M
Mol Syst Biol; 2021 Nov; 17(11):e10396. PubMed ID: 34709727
[TBL] [Abstract][Full Text] [Related]
4. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
Li J; Guo M; Tian X; Wang X; Yang X; Wu P; Liu C; Xiao Z; Qu Y; Yin Y; Wang C; Zhang Y; Zhu Z; Liu Z; Peng C; Zhu T; Liang Q
Med; 2021 Jan; 2(1):99-112.e7. PubMed ID: 32838362
[TBL] [Abstract][Full Text] [Related]
5. RNA-protein interactomes as invaluable resources to study RNA viruses: Insights from SARS CoV-2 studies.
Koliński M; Kałużna E; Piwecka M
Wiley Interdiscip Rev RNA; 2022 Nov; 13(6):e1727. PubMed ID: 35343064
[TBL] [Abstract][Full Text] [Related]
6. An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.
Zhang Y; Shang L; Zhang J; Liu Y; Jin C; Zhao Y; Lei X; Wang W; Xiao X; Zhang X; Liu Y; Liu L; Zhuang MW; Mi Q; Tian C; Wang J; He F; Wang PH; Wang J
Cell Chem Biol; 2022 Jan; 29(1):5-18.e6. PubMed ID: 34672954
[TBL] [Abstract][Full Text] [Related]
7. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N
J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R
J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917
[TBL] [Abstract][Full Text] [Related]
9. Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.
May DG; Scott KL; Campos AR; Roux KJ
Cells; 2020 Apr; 9(5):. PubMed ID: 32344865
[TBL] [Abstract][Full Text] [Related]
10. Host cell membrane proteins located near SARS-CoV-2 spike protein attachment sites are identified using proximity labeling and proteomic analysis.
Kotani N; Nakano T; Kuwahara R
J Biol Chem; 2022 Nov; 298(11):102500. PubMed ID: 36152751
[TBL] [Abstract][Full Text] [Related]
11. AirID, a novel proximity biotinylation enzyme, for analysis of protein-protein interactions.
Kido K; Yamanaka S; Nakano S; Motani K; Shinohara S; Nozawa A; Kosako H; Ito S; Sawasaki T
Elife; 2020 May; 9():. PubMed ID: 32391793
[TBL] [Abstract][Full Text] [Related]
12. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome.
Labeau A; Fery-Simonian L; Lefevre-Utile A; Pourcelot M; Bonnet-Madin L; Soumelis V; Lotteau V; Vidalain PO; Amara A; Meertens L
Cell Rep; 2022 Apr; 39(4):110744. PubMed ID: 35477000
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
[TBL] [Abstract][Full Text] [Related]
14. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J
EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536
[TBL] [Abstract][Full Text] [Related]
15. Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods.
Yu S; Li X; Xin Z; Sun L; Shi J
Front Immunol; 2022; 13():923387. PubMed ID: 36203586
[TBL] [Abstract][Full Text] [Related]
16. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
Hoffmann HH; Schneider WM; Sánchez-Rivera FJ; Luna JM; Ashbrook AW; Soto-Feliciano YM; Leal AA; Le Pen J; Ricardo-Lax I; Michailidis E; Hao Y; Stenzel AF; Peace A; Allis CD; Lowe SW; MacDonald MR; Poirier JT; Rice CM
bioRxiv; 2020 Sep; ():. PubMed ID: 32935098
[TBL] [Abstract][Full Text] [Related]
17. An antibody-based proximity labeling protocol to identify biotinylated interactors of SARS-CoV-2.
Shang L; Zhang Y; Liu Y; Jin C; Zhao Y; Zhang J; Wang PH; Wang J
STAR Protoc; 2022 Jun; 3(2):101406. PubMed ID: 35611119
[TBL] [Abstract][Full Text] [Related]
18. Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs.
Eskandarzade N; Ghorbani A; Samarfard S; Diaz J; Guzzi PH; Fariborzi N; Tahmasebi A; Izadpanah K
Comput Biol Med; 2022 Jul; 146():105575. PubMed ID: 35533462
[TBL] [Abstract][Full Text] [Related]
19. The current landscape of coronavirus-host protein-protein interactions.
Perrin-Cocon L; Diaz O; Jacquemin C; Barthel V; Ogire E; Ramière C; André P; Lotteau V; Vidalain PO
J Transl Med; 2020 Aug; 18(1):319. PubMed ID: 32811513
[TBL] [Abstract][Full Text] [Related]
20. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
Bojkova D; Klann K; Koch B; Widera M; Krause D; Ciesek S; Cinatl J; Münch C
Nature; 2020 Jul; 583(7816):469-472. PubMed ID: 32408336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
